JPWO2021224865A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021224865A5
JPWO2021224865A5 JP2022567142A JP2022567142A JPWO2021224865A5 JP WO2021224865 A5 JPWO2021224865 A5 JP WO2021224865A5 JP 2022567142 A JP2022567142 A JP 2022567142A JP 2022567142 A JP2022567142 A JP 2022567142A JP WO2021224865 A5 JPWO2021224865 A5 JP WO2021224865A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022567142A
Other versions
JP2023525250A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/053864 external-priority patent/WO2021224865A1/en
Publication of JP2023525250A publication Critical patent/JP2023525250A/ja
Publication of JPWO2021224865A5 publication Critical patent/JPWO2021224865A5/ja
Pending legal-status Critical Current

Links

JP2022567142A 2020-05-07 2021-05-06 非リソソームグルコシルセラミダーゼ阻害剤及びその使用 Pending JP2023525250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063021432P 2020-05-07 2020-05-07
US63/021,432 2020-05-07
PCT/IB2021/053864 WO2021224865A1 (en) 2020-05-07 2021-05-06 Non-lysosomal glucosylceramidase inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2023525250A JP2023525250A (ja) 2023-06-15
JPWO2021224865A5 true JPWO2021224865A5 (ja) 2023-11-20

Family

ID=78467881

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567142A Pending JP2023525250A (ja) 2020-05-07 2021-05-06 非リソソームグルコシルセラミダーゼ阻害剤及びその使用

Country Status (14)

Country Link
US (1) US20230174486A1 (ja)
EP (1) EP4146624A4 (ja)
JP (1) JP2023525250A (ja)
KR (1) KR20230008826A (ja)
CN (1) CN115867534A (ja)
AU (1) AU2021269232A1 (ja)
BR (1) BR112022022548A2 (ja)
CA (1) CA3182338A1 (ja)
CO (1) CO2022016514A2 (ja)
CR (1) CR20220601A (ja)
IL (1) IL297972A (ja)
MX (1) MX2022013964A (ja)
PE (1) PE20231424A1 (ja)
WO (1) WO2021224865A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118206479A (zh) * 2022-12-16 2024-06-18 浙江大学 一种1-脱氧野尻霉素衍生物及其应用
CN117844877B (zh) * 2024-01-14 2024-09-06 宿州市东凯医药科技有限公司 一种通过生物酶制备普瑞巴林的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
JPH02306962A (ja) * 1989-05-19 1990-12-20 Meiji Seika Kaisha Ltd 新規ｎ―置換―１―デオキシノジリマイシン誘導体及びそれを含有する癌細胞転移抑制剤
WO1991003242A1 (fr) * 1989-09-07 1991-03-21 Nippon Shinyaku Co., Ltd. Medicament antiviral
EP1030839B1 (en) * 1997-11-10 2004-02-04 G.D. SEARLE & CO. Use of alkylated iminosugars to treat multidrug resistance
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
JP4575156B2 (ja) * 2002-07-17 2010-11-04 アクテリオン ファーマシューティカルズ リミテッド グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体
EP3782655A1 (en) * 2005-05-17 2021-02-24 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
AU2020274430A1 (en) * 2019-05-10 2021-11-25 Alectos Therapeutics Inc. Non-lysosomal glucosylceramidase inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
BR102023014872A2 (ja)
BR102023009641A2 (ja)
BR202022005961U2 (ja)
BR202022001779U2 (ja)
BR202022000931U2 (ja)
JPWO2021224865A5 (ja)
JPWO2020229968A5 (ja)
BY13162U (ja)
BY13158U (ja)
CN307051094S (ja)
CN307049578S (ja)
CN307049145S (ja)
CN307047422S (ja)
BY13140U (ja)
CN307045729S (ja)
BY13170U (ja)
BY13169U (ja)
BY13168U (ja)
BY13167U (ja)
BY13166U (ja)
BY13165U (ja)
BY13164U (ja)
BY13141U (ja)
BY13163U (ja)
CN307051842S (ja)